Last reviewed · How we verify
NCT05936073: DELTADESCRIBE
DELTA DESCRIBE: the French Collaborative Project
trial testing Patients co-infected HBV/HDV in Hepatitis D in 734 participants. Currently enrolling.
22 June 2025
Quick facts
| Lead sponsor | University Hospital, Limoges |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 734 |
| Start date | 22 January 2024 |
| Primary completion | 22 June 2025 |
| Estimated completion | 22 June 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Patients co-infected HBV/HDV
Conditions studied
- Hepatitis D — all drugs for Hepatitis D →
Sponsor
University Hospital, Limoges
Who can join
18 and older, any sex, with Hepatitis D. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our global objective is to draw up a photograph of HDV patients over one year in metropolitan France and identify the barriers of screening and care. The investigator suspects a mismatch between HBV and HDV screening, the first step for specialized care pathway in metropolitan France.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France.
Bosselut M, Carrier P, Brichler S, Alain S, et al · · 2026 · PMID 42043213 · DOI 10.3390/v18040424
Verify or expand the search:
- PubMed search for NCT05936073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatitis D
Currently open trials in the same condition.
- NCT07491848 — Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D · recruiting
- NCT06504485 — Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bule · recruiting
- NCT06397859 — Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrho · recruiting
- NCT06264583 — HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection · recruiting
- NCT05903742 — Standardising Care for Hepatitis Delta in the Netherlands · recruiting
Other University Hospital, Limoges trials
Trials by the same sponsor.
- NCT07407101 — Impact of Filtration on Autologous Serum Eye Drops · NA · not yet recruiting
- NCT07406425 — Evaluation of Efficacy of Coconut Oil Mouth Care for Non-autonomous Hospitalised Elderly People. · NA · not yet recruiting
- NCT07436780 — B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP · not yet recruiting
- NCT07331298 — Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study · not yet recruiting
- NCT07019818 — Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intu · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05936073 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Limoges
- Last refreshed: 28 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05936073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing